LOS ANGELES, July 7, 2015 /PRNewswire/ -- To aid in the ongoing battle against tobacco-based addiction, Redwood Scientific Technologies, Inc. (Redwood) today announced the launch of TBX-FREE: a new thin film over-the-counter smoking cessation medication that features a key ingredient which mimics the sensation of smoking without any of the harmful side effects.
TBX-FREE has been designed with the intention that cigarette addiction should not be treated with continued nicotine use just as alcoholism should not be treated with reduced amounts of alcohol. TBX-FREE is unique among smoking cessation products because it is devoid of any nicotine.
The key ingredient in TBX-FREE has had its efficiency and efficacy proven by 236 research studies that included clinical trials. It is currently being used for the treatment of nicotine addiction in parts of Asia and Europe.
"We are now proud to be able to synthesize such an incredibly proven ingredient and put it into the form of dissolvable strip delivery technology so that people who suffer with addiction to tobacco-based cigarettes can have over-the-counter access to a smoking cessation treatment that does not use nicotine while enjoying the freedom to live without fear of death," said Jason Cardiff, President and CEO of Redwood, who has made it his mission to combat cigarette addiction in the wake of his mother's death from smoking-related disease.
Ben England, Founder and CEO at FDAImports.com, LLC, will be overseeing the FDA registration process for TBX-FREE.
"We are very excited about the idea of a new treatment to help with nicotine addiction and look forward to working with Redwood and their revolutionary delivery method for the treatment of nicotine addiction," said England.
TBX-FREE will come packaged in the form of discrete thin film containers that look identical to breath freshening strips so that smokers can have it on hand to help quickly address cravings and withdrawal symptoms associated with quitting smoking.
TBX-FREE will be the second product from the Redwood product pipeline and is scheduled to launch in the third quarter of 2016.
About Redwood Scientific Technologies, Inc.
Redwood Scientific Technologies, Inc. (Redwood), headquartered in Claremont, California, develops and markets FDA registered OTC drugs that can be delivered through the use of thin film technology. Redwood utilizes patent pending sublingual strip delivery technology to enhance the effectiveness and absorption rate in the treatment of medical conditions. The company is aggressively expanding its customer population through national television advertising campaigns while driving consumer awareness and increasing retail expansion.
SOURCE Redwood Scientific Technologies, Inc.